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CytotoxicityThe polyubiquitin gene Ubc is upregulated under oxidative stress induced by arsenite [As(III)]. However, the de-
tailedmechanism ofUbc upregulation and the exact role of ubiquitin (Ub) to protect cells against As(III)-induced
toxicity remain unknown. Here, we found that Ubc−/−mouse embryonic ﬁbroblasts (MEFs) exhibited reduced
viability under As(III) exposure, although the Nrf2–Keap1 pathway was activated as a cytoprotective response.
Intriguingly, due to the reduced polyubiquitination and delayed onset of degradation of Nrf2 in Ubc−/−MEFs,
the basal expression levels of Nrf2 target genes were elevated. As(III)-induced accumulation of Ub conjugates
occurred in an Nrf2-independent manner, probably due to cellular stress conditions, including reduced
proteasomal activity. Increased cellular Ub levels were essential to polyubiquitinate misfolded proteins generat-
ed under As(III) exposure and to degrade them by the proteasome. However, when cellular Ub levels decreased,
these misfolded proteins were not efﬁciently polyubiquitinated, but rather accumulated as large protein aggre-
gates inside the cells, causing cytotoxicity. Furthermore, increased activity of the autophagic pathway to clear
these aggregates was not observed in Ubc−/−MEFs. Therefore, reduced viability of Ubc−/−MEFs under As(III)
exposure may not be due to dysregulation of the Nrf2–Keap1 pathway, but mostly to reduced efﬁcacy to
polyubiquitinate and degrade misfolded protein aggregates.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Oxidative stress is induced when cellular levels of reactive oxygen
species (ROS) outbalance their antioxidant response capacity, which re-
sults in perturbation of the cellular redox state by producing peroxides
and free radicals that damage DNA, proteins, and lipids [1–5]. Upon
exposure to oxidative stress, the cellular stress response pathway is
activated to increase the likelihood of survival [6]. Cellular defense
against toxicity caused by oxidative stress is achieved by upregulating
the cytoprotective antioxidant genes through the activation of
mitogen-activated protein kinases (MAPKs) and the pathway involving
nuclear factor erythroid 2-related factor 2 (Nrf2) and Kelch-like ECH-
associated protein 1 (Keap1) [7]. Impairment in Nrf2-mediated cellular
defense mechanisms is related to various diseases, including cancer,
cardiovascular diseases, and neurodegenerative diseases [8–13].
The Nrf2–Keap1 pathway is the major antioxidant response path-
way [1–5,14,15]. Nrf2 is a transcription factor that induces the ex-
pression of genes harboring antioxidant response element (ARE) in
their promoter region [16–20]. Under normal conditions, Nrf2 is
polyubiquitinated by the Keap1-Cul3 E3 ligase complex and is rapidlynce, University of Seoul, 163
blic of Korea. Tel.: +82 2 6490degraded by the 26S proteasome with a half-life of b20 min, thereby
maintaining its protein levels quite low in the cytoplasm [21–24].
However, under oxidative or electrophilic stress conditions, the critical
Cys residues of Keap1 are modiﬁed; therefore, the E3 ligase complex
cannot be formed andNrf2 no longer serves as a target [25–28]. Alterna-
tively, autophagy deﬁciency or arsenite [As(III)] exposure induces the
accumulation of p62, an autophagy adaptor protein, which directly
binds to Keap1 and leads to the sequestration of Keap1 to the
autophagosome; therefore, E3 ligase complex cannot be formed
[29–31]. As a result, Nrf2 is released and becomes stabilized, enters
the nucleus, and induces the transcription of target genes that encode
detoxifying enzymes and antioxidant proteins. p62 is also a known tar-
get of Nrf2, creating a positive feedback loop for prolonged activation of
Nrf2 [32]. AlthoughNrf2mostly exerts a protective role against cytotox-
icity [33], it can also be harmful as cancer cells are also protected by
Nrf2. In fact, the constitutive activation of Nrf2 has been reported in
various tumors or chemoresistance of cancer cells [7,11,34–36].
Furthermore, As(III) exposure not only leads to prolonged activation
of Nrf2 but also to increased levels of ubiquitin (Ub) conjugates [37].
In addition, the polyubiquitin gene Ubc is upregulated upon exposure
to As(III) [38]. However, the detailed mechanism of Ubc upregulation
and the exact role of Ub to protect cells under As(III) exposure remain
unknown.
Ub is a well conserved eukaryotic protein composed of 76 amino
acids [39–41]. As a post-translational modiﬁcation of the protein
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E1 activating enzymes, E2 conjugation enzymes, and E3 ligases.
Ubiquitination of substrates can be divided into two major classes.
Monoubiquitination plays a role in endocytosis and histone modiﬁca-
tion [42], whereas polyubiquitination plays a role in proteasomal degra-
dation, regulation of the cell cycle, DNA repair, and kinase activation
depending on Ub chain linkage [43]. Among these, the most important
and well-known role of Ub is the degradation of proteins by targeting
them to the 26S proteasome. Due to the diverse roles of Ub in cellular
signaling and function, maintaining cellular Ub levels is important for
cell survival. In particular, disruption of cellular Ub homeostasis
has been thought to inﬂuence resistance against oxidative stress, al-
though the detailed mechanism has yet to be identiﬁed. Therefore, we
investigated the relationship between cellular Ub levels and integrity
of the antioxidant response pathway.
First, we found that Ubc−/−mouse embryonic ﬁbroblasts (MEFs), in
which cellular Ub levels decreased due to the disruption ofUbc, exhibit-
ed reduced viability under oxidative stress induced by As(III). Based on
this observation, we hypothesized that maintenance of cellular Ub
levels is important for the antioxidant response, and we tested our hy-
pothesis by investigating whether or not activation of the Nrf2–Keap1
pathway via tert-butylhydroquinone (tBHQ) or As(III) exposure is
dependent on cellular Ub levels. Next, as it is known thatmisfolded pro-
teins generated under As(III) exposure are polyubiquitinated to be de-
graded by the 26S proteasome [44,45], and As(III) is also known to
trigger the formation of protein aggregates in yeast [46], we looked
into this possibility in MEFs treated with As(III). Misfolded proteins
could not be adequately polyubiquitinated in Ubc−/−MEFs, potentially
resulting in aggregation of these proteins instead of being targeted to
the proteasome. In fact, we demonstrated that the number of large
protein aggregates increased signiﬁcantly when cellular Ub levels
decreased under As(III) exposure.
Here, we demonstrate that degradation and stabilization of Nrf2 is
tightly regulated in MEFs in the absence and presence of oxidative
stress, respectively. In contrast, when cellular Ub levels decreased,
cellular desensitization against oxidative stress may occur due to the
presence of Nrf2 spared from degradation, even under normal or un-
stressed conditions. However, the overall function of Nrf2 was intact,
and impairment in the Nrf2–Keap1 pathway was not observed in
Ubc−/− MEFs under As(III) exposure. Rather, the Nrf2-independent
pathway also plays an important role in increasing cellular Ub levels
via upregulation of Ubc under As(III) exposure, which is required for
polyubiquitination and degradation of misfolded proteins. However,
when cellular Ub levels decreased, these misfolded proteins accumulat-
ed as large protein aggregates with delayed clearance. In sum, the re-
duced viability of Ubc−/− MEFs under oxidative stress induced by
As(III) seemed to be mostly due to toxicity caused by the accumulated
misfolded protein aggregates.
2. Materials and methods
2.1. Mouse studies
Ubc+/−(eGFP-puro) (or simply Ubc+/−), Ubb+/−(eGFP-puro) (or simply
Ubb+/−), Nrf2+/−, and Nrf2−/− mice were maintained in plastic cages
with ad libitum access to food and water. Breeding pairs of Nrf2−/−
mice were kindly donated by Dr. Sue Goo Rhee at Ewha Womans
University (currently at Yonsei University). All animal procedures
were approved by the University of Seoul Institutional Animal Care
and Use Committee (UOS IACUC; UOS-091201-1 and UOS-121025-2).
2.2. Isolation and culture of mouse embryonic ﬁbroblasts
Mouse embryonic ﬁbroblasts (MEFs) were generated from 13.5-day
post-coitummouse embryos, as previously described [47]. Either wild-
type or heterozygous (Ubc+/− or Nrf2+/−) MEFs served as a control, asthere were no discernable phenotypes when only one Ubc or Nrf2 allele
was deleted, as previously described [47–49].2.3. Cell viability assay
MEFs were treated with the indicated concentration of sodium arse-
nite (NaAsO2) [As(III)] for 12 h. The cell viability assaywas carried out as
previously described [47].2.4. Immunoﬂuorescence analysis and TUNEL assay
For immunoﬂuorescence, MEFs grown on coverslips were ﬁxed in
4% paraformaldehyde for 15 min at room temperature (RT), perme-
abilized with 0.4% Triton X-100/PBS, and blocked with 3% BSA/PBS for
1 h at RT. Fixed cells were incubated with anti-Ub (FK2; 1:1000,
Millipore) and anti-Nrf2 (sc-722; 1:500, Santa Cruz Biotechnology) an-
tibodies at 4 °C overnight, washed with 0.05% Tween 20/PBS, and incu-
bated with Alexa Fluor 488-conjugated goat anti-mouse IgG (1:1000,
Invitrogen) and Alexa Fluor 555-conjugated goat anti-rabbit IgG
(1:1000, Invitrogen) along with 0.1 μg/ml of DAPI for 1 h at RT. Cells
were then mounted using ProLong Gold antifade reagent (Invitrogen)
and visualized with a Carl Zeiss AxioImager A2 microscope. The
number of Ub-positive puncta and their size were determined by
ImageJ particle analysis software (1.47v). Brieﬂy, 8-bit grayscale im-
ages were thresholded to highlight all of the particles to be counted.
Particles with sizes ranging from 0 to inﬁnity in2 were counted and
divided into four groups based on their size. Extra small puncta (par-
ticle area b 5 × 10−5 in2) were assigned to group 0, small puncta
(5 × 10−5 in2 ≤ particle area b 2.5 × 10−4 in2) were assigned to group
1, medium puncta (2.5 × 10−4 in2 ≤ particle area b 6.5 × 10−4 in2)
were assigned to group 2, and large puncta (particle area ≥ 6.5 ×
10−4 in2) were assigned to group 3. To detect NaAsO2-induced apopto-
sis in MEFs, the TUNEL (terminal deoxynucleotidyl transferase dUTP
nick-end labeling) assay was performed using an Apoptag® red in situ
apoptosis detection kit according to the manufacturer's protocol
(Millipore).2.5. Immunoblot analysis and indirect competitive Ub-ELISA
Cell lysates were prepared in RIPA buffer [25 mM Tris–HCl (pH 7.6),
150mMNaCl, 1% NP-40, 1% sodium deoxycholate, 0.1% SDS, with 1mM
PMSF, 1 μg/μl aprotinin, and 1 μg/μl leupeptin as protease inhibitors] and
incubated on ice for 20–30 min. Total cell lysates were centrifuged at
15,000 ×g for 10 min at 4 °C, and the supernatant was then removed
to measure protein concentration using the BCA protein assay (Pierce).
The total cell lysates (15 μg) were subjected to SDS-PAGE followed by
immunoblot detection with anti-GFP (MAB3580; 1:500, Millipore),
anti-Ub (MAB1510; 1:500, Millipore), anti-Ub (SPA200; 1:1000, Enzo
Life Sciences), anti-Nrf2 (sc-722; 1:1000, Santa Cruz Biotechnology),
anti-Keap1 (sc-15246; 1:200, Santa Cruz Biotechnology), anti-Nqo1
(ab34173; 1:3000, Abcam), anti-Hmox1 (#5061; 1:3000, Cell Signaling
Technology), anti-Hsp70 (SPA810; 1:1000, Enzo Life Sciences), anti-
Hsf1 (SPA901; 1:2000, Enzo Life Sciences), anti-SQSTM1/p62 (#5114;
1:500, Cell Signaling Technology), anti-LC3B (#2775; 1:2000, Cell Sig-
naling Technology), anti-Lamin B (sc-6217; 1:1000, Santa Cruz Biotech-
nology), or anti-α-tubulin antibody (T6199; 1:5000, Sigma-Aldrich).
Based on the type of primary antibodies, we used appropriate secondary
antibodies; HRP conjugated goat anti-mouse or anti-rabbit IgG
(1:10,000, Enzo Life Sciences) or HRP conjugated donkey anti-goat IgG
(1:10,000, Santa Cruz Biotechnology). Immunoreactive complexes
were visualized using ECL Plus western blotting substrate (Pierce).
The membranes were exposed to X-ray ﬁlm (Hyperﬁlm® ECL) and
developed. Indirect competitive ELISA was carried out as previously
described [47,50,51].
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A cell pellet was resuspended in a homogenizing buffer [0.25 M su-
crose, 5 mM NaCl, 0.1 M Tris–HCl (pH 7.5), 1 mM EDTA, 1 mM PMSF,
1 μg/μl aprotinin, and 1 μg/μl leupeptin as protease inhibitors] and incu-
bated on ice for 10 min. The cells were lysed using a tissue grinder with
50 up-and-down strokes to release nuclei. Homogenized cell lysates
were centrifuged at 700 ×g for 10 min at 4 °C, and the supernatant
was collected as a cytosolic fraction. The pellet waswashed in a homog-
enizing buffer and centrifuged at 10,000 rpm for 3 min at 4 °C, and the
supernatant was then removed. The washed pellet was resuspended
in RIPA buffer using a 26-gauge needle and incubated on ice for
30min, then centrifuged at 13,000 rpm for 10min at 4 °C. The superna-
tant was then collected as a nuclear fraction. Protein concentrations of
both nuclear and cytosolic fractions were determined using the BCA
protein assay (Pierce). Nuclear or cytoplasmic fractions (15 μg) were
subjected to SDS-PAGE followed by immunoblot detection with
appropriate antibodies as described above.
2.7. Quantitative real-time RT-PCR
Total RNA was isolated from cultured MEFs using the RNeasy kit
(Qiagen). RNA concentration was determined, 0.4–1 μg of total RNA
was used for reverse transcription, and 1/10 to 1/20 of the resulting
cDNA sample was used as a template for PCR. Before reverse transcrip-
tion, DNase I (ampliﬁcation grade, Invitrogen) was treated for 15min at
RT. Reverse transcription and quantitative real-time RT-PCR (qRT-PCR)
were carried out as previously described [52]. The mRNA expression
levels of Ubb, Ubc, Nrf2, Nqo1, and Hmox1were normalized to the level
of Gapdh. The primers used for qRT-PCR are as follows: Ubb-F (5′-TCT
GAG GGG TGG CTA TTA A-3′); Ubb-R (5′-TGC TTA CCA TGC AAC AAA
AC-3′); Ubc-F (5′-GTT ACC ACC AAG AAG GTC-3′); Ubc-R (5′-GGG AAT
GCA AGA ACT TTA TTC-3′); Nrf2-F (5′-ATC CAG ACA GAC ACC AGT
GGA TC-3′); Nrf2-R (5′-GGC AGT GAA GAC TGA ACT TTC A-3′); Nqo1-F
(5′-GGT AGC GGC TCC ATG TAC TC-3′); Nqo1-R (5′-CAT CCT TCC AGG
ATC TGC AT-3′); Hmox1-F (5′-CCT GGT GCA AGA TAC TGC CC-3′);
Hmox1-R (5′-GAA GCT GAG AGT GAG GAC CCA-3′); Gapdh-F (5′-GGC
ATT GCT CTC AAT GAC AA-3′); Gapdh-R (5′-CTT GCT CAG TGT CCT
TGC TG-3′).
2.8. Transfection and luciferase assay
To test whether Ubc is the direct target of Nrf2, we analyzed the
~1.5 kb promoter region of Ubc and found a sequence that resembles
the core consensus sequence of ARE at−457 to−449 bp upstream of
the transcriptional start site (see Supplementary Fig. S1).Wedesignated
this sequence (TGAGgagGC) as the core sequence of a putative ARE
based on the widely accepted ARE core consensus sequence [T(G/T)
A(C/T)nnnGC], the mouse Nqo1 ARE core sequence (TGAGtcgGC), and
the de novo motif discovered by ChIP-Seq analysis [TGA(C/G)nnnGC],
as previously reported [53–55].
A DNA fragment containing 1101-bp 5′-ﬂanking region of Nqo1 and
a DNA fragment containing 1461-bp 5′-ﬂanking region of Ubcwere am-
pliﬁed via PCR with a Platinum Taq DNA Polymerase (Invitrogen) using
mouse genomic DNA as a template. Primers used for PCR are as follows:
Nqo1-promoter-F (5′-ATC CGC TCG AGT GTC TAC CCT ACT TTG GGA G-
3′);Nqo1-promoter-R (5′-ATC CCAAGC TTA TCG TAA TAC CGAACGCTG
A-3′);Ubc-promoter-F (5′-ATCCGC TCGAGTATTGAA TTCATGTAC TCT
GG-3′); Ubc-promoter-R (5′-ATC CAA AGC TTC GCA GTC TCC ACG GAA
CTA GC-3′). The ampliﬁed fragments were cloned into the XhoI and
HindIII sites of the pGL3-Basic vector (Promega). These constructs
were designated as pGL3-Nqo1-ARE and pGL3-Ubc-1460, respectively.
The pGL3-Ubc-710 construct containing 706-bp 5′-ﬂanking region of
Ubc was obtained by removing a ~750-bp XbaI/BglII fragment from
pGL3-Ubc-1460, followed by blunting and self-ligation. The pGL3-Ubc-
450 construct containing 452-bp 5′-ﬂanking region ofUbcwas obtainedby removing a ~1 kb XbaI/BamHI fragment (partial digestion with
BamHI) from pGL3-Ubc-1460, followed by blunting and self-ligation.
The pGL3-Ubc-170 construct containing 173-bp 5′-ﬂanking region of
Ubc was obtained by removing a ~1.3-kb KpnI fragment from pGL3-
Ubc-1460, followed by self-ligation.
For the luciferase assay, HEK-293T cells (2 × 105 cells/well) were
seeded on 12-well plate one day before transfection, and transiently
transfected with 200 ng of pGL3-Nqo1-ARE as a positive control,
pGL3-Basic as a negative control, pGL3-Ubc-1460, pGL3-Ubc-710,
pGL3-Ubc-450, or pGL3-Ubc-170 construct with pGL4.74[hRluc/TK]
using the CaPO4 precipitation method. Sixteen h after transfection,
the cells were treated with the indicated concentration of tert-
butylhydroquinone (tBHQ, Sigma-Aldrich) or DMSO for 24 h and har-
vested in 125 μl of 1× passive lysis buffer (Promega). The dual luciferase
assay was performed according to the standard procedure using a
GLOMAX 20/20 luminometer (Promega).2.9. Fluorescence plate reader assay
The ﬂuorescence plate reader assay was carried out as previously
described [38]. Brieﬂy, 16 h after plating 2 × 104 Ubb+/−(eGFP-puro)
(or simply Ubb+/−) or Ubc+/−(eGFP-puro) (or simply Ubc+/−) MEFs
into each well of a 96-well plate, the MEFs were treated with tBHQ
in the presence or absence of 50 μg/ml emetine. After a 12-h incuba-
tion, the medium was removed and washed in PBS, after which the
ﬂuorescence was measured using a ﬂuorescence plate reader
(SpectraMax M2e, Molecular Devices). Fluorescence (RFU; relative
ﬂuorescence units) was read from the bottoms of the plates at exci-
tation and emission wavelengths of 485 nm and 525 nm, respective-
ly. An emission cutoff ﬁlter of 515 nm was used to reduce the
background ﬂuorescence.2.10. Proteasome activity assay
Cell lysates were prepared in a lysis buffer containing 50 mMHEPES
(pH 7.5), 150mMNaCl, 5 mM EDTA, 1% Triton X-100, with 1mMPMSF,
1 μg/μl aprotinin, and 1 μg/μl leupeptin as protease inhibitors. To mea-
sure chymotrypsin-like activity, the ﬂuorogenic substrate, Suc-LLVY-
AMC (APT280, Millipore), was added and assays were performed
according to the manufacturer's protocol. Proteasome activities were
determined from the intensity of free AMC generated from the cleavage
of the substrate. The integrity of the assay was conﬁrmed by including
2.5 μM lactacystin during the assay, which reduced proteasome activi-
ties by ~90%. Fluorescence was measured using a ﬂuorescence plate
reader (SpectraMaxM2e, Molecular Devices) at excitation and emission
wavelengths of 380 nm and 460 nm, respectively. An emission cutoff
ﬁlter of 435 nm was used, and the background ﬂuorescence was
subtracted from each RFU.2.11. Detection of polyubiquitinated proteins by TUBEs
Cell lysates were prepared in TUBEs (Tandem Ubiquitin Binding En-
tities) lysis buffer [50mMTris–HCl (pH 7.5), 150mMNaCl, 1mMEDTA,
1% NP-40, 10% glycerol, 50 μM PR-619 as a deubiquitinase inhibitor,
with 1mMPMSF, 1 μg/μl aprotinin, and 1 μg/μl leupeptin as protease in-
hibitors] and protein concentration in total cell lysates was determined
as described above. To enrich and isolate polyubiquitinated proteins, the
TUBEs pull down assay was performed using Agarose-TUBEs (UM402;
LifeSensors), which is composed of four Ub-associated (UBA) domains,
according to the manufacturer's protocol. Input (5% of total cell lysates,
10 μg) and elution fractions (200 μg) were subjected to SDS-PAGE
followed by immunoblot detection with appropriate antibodies as
described above.
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The oligonucleotide targeting sequence for mouse Nrf2 was 5′-CCA
AAG CTA GTA TAG CAA TAA-3′. The pLKO.1-scRNA vector was obtained
from Addgene and digested with AgeI/EcoRI to remove the scrambled
oligonucleotide. The annealed oligonucleotides for Nrf2were inserted
into the AgeI and EcoRI sites of the pLKO.1 vector. The oligonucleotide
sequences used for hybridization are as follows: shNrf2-sense (5′-CCG
GCC AAA GCT AGT ATA GCA ATA ACT CGA GTT ATT GCT ATA CTA GCT
TTG GTT TTT G-3′); shNrf2-antisense (5′-AAT TCA AAA ACC AAA GCT
AGT ATA GCA ATA ACT CGA GTT ATT GCT ATA CTA GCT TTG G-3′).
The resulting construct was conﬁrmed by DNA sequencing and desig-
nated as pLKO.1-shNrf2.
To produce a lentivirus harboring shNrf2, packaging plasmid
psPAX2 (8 μg), envelope plasmid pMD2.G (3 μg), and transfer plas-
mid pLKO.1-shNrf2 (10 μg), were transfected into the HEK-293T
cells and the viral pellet was obtained as previously described [56].
The MEFs were infected with lentivirus harboring scrambled or
Nrf2 shRNA for 16 h and cultured for another 48–72 h before harvest-
ing the infected cells.
2.13. Statistical analysis
Two-tailed unpaired Student's t-tests were used to compare the
data between two groups. Although P b 0.05 was considered to beFig. 1. Enhanced sensitivity ofUbc−/−MEFs to oxidative stress induced byAs(III). (A)MTT cell v
KO (Ubc−/−)MEFs (n=3each)were treatedwith the indicated concentrations ofNaAsO2 for 12
effect of NAC, 10 mM NAC was added 2 h before NaAsO2 treatment. (B) Control (Ubc+/−) and
TUNEL assay. Arrowheads indicate TUNEL+ apoptotic cells. To determine the percentage of TUN
three randomly selected ﬁelds for each sample. Representative images from three different M
number of samples. ⁎P b 0.05; ⁎⁎P b 0.01; ⁎⁎⁎P b 0.001 vs. control MEFs on each concentrationstatistically signiﬁcant in most cases, P b 0.1 was also noted in
some cases.
3. Results
3.1. Reduced viability and increased apoptosis of Ubc−/− MEFs under
As(III) exposure
We have previously demonstrated that the polyubiquitin genes Ubb
and Ubc are upregulated in response to oxidative stress induced by
As(III) [38]. This result indicates that the demand for cellular Ub in-
creases upon exposure to As(III); however, the outcome if this require-
ment is not achieved is currently unknown. To identify the role of Ub
under oxidative stress triggered by As(III), we ﬁrst determined the via-
bility ofUbb−/− andUbc−/−MEFs. Due to the higher contribution ofUbc
toward total Ub levels than that of Ubb, the total Ub levels decreased by
~40% in Ubc−/−MEFs, even under normal conditions [47], whereas the
decrease in cellular Ub levels in Ubb−/−MEFs was minimal (data not
shown). Upon exposure to As(III), the viability of Ubc−/− MEFs, but
not Ubb−/− MEFs, decreased signiﬁcantly compared to control MEFs
(Fig. 1A, left). Therefore, the viability ofMEFs exposed to As(III) was cer-
tainly inﬂuenced by their cellular Ub levels. To determine whether the
reduced viability of Ubc−/−MEFs is related to the increased production
of reactive oxygen species (ROS), we investigated the effect of ROS scav-
enger NAC on the viability of Ubc−/− MEFs exposed to As(III). Wheniability assay forMEFs under As(III) exposure. Control (Ubc+/−),UbbKO (Ubb−/−), andUbc
h. Then, the viabilitywas assessed by thepercentage ofMTT conversion. To investigate the
Ubc KOMEFs (n= 3 each) were treated with 10 μMNaAsO2 for 10 h and subjected to the
EL+ cells, the number of TUNEL+ cells was divided by the total number of DAPI+ cells in
EFs per group are shown. All data are expressed as the means ± SEM from the indicated
(A) or between two groups as indicated by horizontal bars (B). Scale bar, 100 μm.
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(Fig. 1A, right). Therefore, the reduced viability of Ubc−/−MEFs upon
exposure to As(III) is related to the increased production of ROS. In ad-
dition, upon exposure to As(III), TUNEL+ cells were observed frequently
in Ubc−/− MEFs, but very rarely in control and Ubb−/− MEFs (Fig. 1B
and data not shown). Therefore, cells that could not overcome theFig. 2. IncreasedUbc expression due to activation of the Nrf2–Keap1 pathway. (A)Ubb+/− orUb
the presence or absence of emetine, and the ﬂuorescence from the MEFs was measured. The
polyubiquitin genes to tBHQ treatment, was calculated. (B) Ubb and UbcmRNA levels in contr
were determined by qRT-PCR. ThemRNA levels are expressed as a fold increase relative to contr
reporter constructs in HEK-293T cells. Cells were transiently transfected with various deletion
resent two independent experiments, and triplicate transfectionswere performed in each exper
MEFs treatedwith 10 μMNaAsO2 or 40 μMtBHQ for up to 10 h.Ubc expressionwasmonitored b
immunoblot results from three differentMEFs are shown. (E) Control (Ubc+/−) andUbcKOMEF
to proteasome assay. (F) Control (Ubc+/−) and Ubc KO MEFs (n= 4 each) were treated with
without Usp2-cc treatment. All data are expressed as the means ± SEM from the indicated n
concentration (A), vs. DMSO treatment for each construct (C), vs. control MEFs on each time (Ecytotoxicity caused by As(III) may undergo apoptosis. These results
suggest that Ub plays an essential role in conferring resistance against
cytotoxicity induced by As(III). Furthermore, this raises the question
whether activation of the Nrf2–Keap1 pathway, the major antioxidant
pathway in cells, and its cytoprotective response are dependent on
cellular Ub levels.c+/−MEFs (n=3each)were treatedwith tBHQ for 12h at the indicated concentrations, in
increase in ﬂuorescence due to newly synthesized GFP, which is the true response of the
ol (Nrf2+/−) and Nrf2 KO (Nrf2−/−) MEFs (n= 3 each) treated with 40 μM tBHQ for 5 h
olMEFs without tBHQ treatment. (C) Transient expression analysis of promoter-luciferase
constructs and treated with tBHQ or DMSO for 24 h before luciferase assay. The data rep-
iment. (D) Immunoblot detection of Ub conjugates (Ubn), freeUb (Ub1), andGFP inUbc+/−
y theGFP band intensity.α-Tubulin (α-Tub)was used as a loading control. Representative
s (n=3each)were treatedwith 10 μMNaAsO2 or 40 μMtBHQ for up to 10h and subjected
40 μM tBHQ, 10 μM NaAsO2, or 5 μMMG-132 for 10 h and subjected to Ub-ELISA with or
umber of samples. #P b 0.1; ⁎P b 0.05; ⁎⁎P b 0.01; ⁎⁎⁎P b 0.001 vs. Ubb+/−MEFs on each
), or between two groups as indicated by horizontal bars (B, E, F). NS, not signiﬁcant.
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pathway
To determine whether upregulation of Ubb and Ubc under As(III)
exposure is mediated by activation of the Nrf2–Keap1 pathway, we
treated Ubb+/− and Ubc+/−MEFswith tBHQ, a well-knownNrf2 activa-
tor, andmonitored the GFP ﬂuorescence as a direct indicator of Ubb and
Ubc transcriptional activity [38]. The GFP ﬂuorescence of both MEFs in-
creased in a dose-dependent manner after treatment with tBHQ
(Fig. 2A), with a signiﬁcantly higher ﬂuorescence increase in Ubc+/−
MEFs. In accordance with the GFP ﬂuorescence data, UbcmRNA levels
dramatically increased following tBHQ treatment in control MEFs, but
not in Nrf2−/− MEFs (Fig. 2B, right). Although GFP ﬂuorescence of
Ubb+/− MEFs also increased following tBHQ treatment (Fig. 2A), Ubb
was only slightly upregulated in both control and Nrf2−/− MEFs
(Fig. 2B, left). Therefore, under As(III) exposure, upregulation of Ubc,
but not Ubb, is mediated by activation of the Nrf2–Keap1 pathway.
As Ubc is upregulated by activation of the Nrf2–Keap1 pathway, Ubc
may be the direct target of Nrf2. To test this possibility, transcriptional
activities of various lengths of the Ubc 5′-ﬂanking region were deter-
mined (Fig. 2C). Upon tBHQ treatment, the transcriptional activities of
the promoter constructs containing a putative ARE increased by ~2-
fold, while those without a putative ARE did not change, suggesting
that a putative ARE site located at−457 to−449 bp upstream of the
transcriptional start site involves direct binding of Nrf2 under oxidative
stress for the transcriptional activation of Ubc (see Supplementary
Fig. S1). Our data is also supported by the observation that Ubc is one
of the genes found near the Nrf2-binding AREs identiﬁed by ChIP-Seq
analysis [54,55]. Combined together, it is highly likely that Ubc is the
direct target of Nrf2.
Intriguingly, upregulation of Ubc in MEFs treated with tBHQ did not
result in increased levels of Ub conjugates, in contrast to cells treated
with NaAsO2 (Fig. 2D), although GFP immunoreactivity increased in a
time-dependent manner in Ubc+/−MEFs treated with either tBHQ or
NaAsO2 (Fig. 2D). As(III)-induced accumulation of Ub conjugates could
not only be due toUbc upregulation but also to reduced proteasomal ac-
tivity. In fact, proteasomal activity decreased signiﬁcantly upon NaAsO2
treatment, but not merely by simple activation of the Nrf2–Keap1 path-
way (Fig. 2E). Our immunoblot resultswere also conﬁrmed byUb-ELISA
with or without deubiquitinating enzyme Usp2-cc treatment. As previ-
ously demonstrated [51], antibodies used for Ub-ELISA prefer free Ub to
Ub conjugates; therefore, the difference of Ub levels with or without
Usp2-cc treatment serves as a good indicator of Ub conjugate levels.
Based on these properties, we conﬁrmed that Ub conjugate levels did
not further increase upon tBHQ treatment compared to control (PBS)
(Fig. 2F). Therefore, accumulation of Ub conjugateswas hardly expected
with tBHQ treatment. Combined together, the accumulation of Ub
conjugates with NaAsO2 treatment could more likely be due to reduced
proteasomal activity and oxidative stress conditions, but not to Ubc up-
regulation via activation of the Nrf2–Keap1 pathway.3.3. Levels of Ub conjugates increased in control MEFs in an Nrf2-
independent manner after exposure to As(III), but not in Ubc−/−MEFs
Ub conjugate levels in control andUbc−/−MEFswere determined by
immunoblot analysis to investigate whether or not the accumulation of
Ub conjugates under As(III) exposure is affected by the availability of
cellular Ub pools. Ub conjugate levels did not increase in Ubc−/−MEFs
treated with NaAsO2, although they dramatically increased in control
MEFs (Fig. 3A). In addition, the levels of free Ub decreased in Ubc−/−
MEFs (Fig. 3A and B). Interestingly, the Nrf2–Keap1 pathway was
activated in both control and Ubc−/− MEFs upon treatment with
NaAsO2 or tBHQ, based on the rapid stabilization of Nrf2 (Fig. 3A
and B). Therefore, activation of the Nrf2–Keap1 pathway was insufﬁ-
cient to increase the levels of Ub conjugates in Ubc−/−MEFs.Ub conjugate levels inNrf2−/−MEFswere determined to investigate
whether or not activation of the Nrf2–Keap1 pathway is necessary to
increase the levels of Ub conjugates after exposure to As(III). To our sur-
prise, the levels of Ub conjugates increased to a similar extent even in
Nrf2−/−MEFs exposed to As(III) (Fig. 3C). In addition, UbcmRNA levels
further increased following NaAsO2 treatment in control MEFs, than in
Nrf2−/−MEFs (Fig. 3D, right), suggesting that upregulation ofUbc isme-
diated by both Nrf2-dependent and independent pathways. Ubb was
also slightly upregulated, but this upregulation was independent of
the presence of Nrf2 (Fig. 3D, left). As the contribution of Ubb toward
total Ub levels in MEFs is much lower than that of Ubc, the levels of Ub
conjugates also increased in Ubb−/−MEFs due to the presence of Ubc,
as in control MEFs (Fig. 3E). These results suggest that the levels of Ub
conjugates increased in control MEFs in an Nrf2-independent manner
upon exposure to As(III), probably due to the reduced proteasomal
activity (see Fig. 2E) and to the misfolded proteins generated under
oxidative stress. These misfolded proteins are destined to be
polyubiquitinated and targeted to the proteasome, unless they undergo
a refolding process. Taken together, upregulation ofUbc does not neces-
sarily result in increased levels of Ub conjugates. Rather, the levels of Ub
conjugates seemed to be more directly correlated with the severity of
cellular stress.
3.4. Onset of Nrf2 degradation is delayed in Ubc−/− MEFs under normal
conditions
Although Nrf2 seemed to be readily stabilized upon exposure to
As(III) regardless of cellular Ub levels, we exploited a more quantitative
approach to investigate the possibility of whether the regulation of the
Nrf2–Keap1 pathway was affected by cellular Ub levels. Under normal
conditions, Nrf2 is polyubiquitinated by E3 ligase complexes containing
Keap1, and is rapidly degraded by the proteasome [21–23]. Due to the
rapid degradation of polyubiquitinated Nrf2, the basal levels of Nrf2
were quite low inside the cells, and the Nrf2-immunoreactive band
was barely detectable in the total cell lysates from both control
and Ubc−/− MEFs (Fig. 4A). However, a signiﬁcant accumulation of
Nrf2 was observed upon inhibition of the proteasomal activity with
MG-132 in both MEFs (Fig. 4A). When these cells were chased in the
presence of cycloheximide to block de novo protein synthesis after
washing out MG-132, Nrf2 was degraded in control MEFs in a time-
dependent manner, whereas the onset of Nrf2 turnover was delayed
in Ubc−/−MEFs during the initial 30 min chase period (Fig. 4A and B).
In contrast, the protein levels of the E3 ligase adaptor Keap1 and the
Nrf2 target Nqo1 did not change with proteasome inhibition, and they
were not degraded during the chase period (Fig. 4A).
When polyubiquitinated proteins were pulled down with TUBEs
under proteasome inhibition and detected with anti-Nrf2 antibody,
the levels of Nrf2, which were pulled down either as polyubiquitinated
proteins or together with polyubiquitinated proteins, decreased signiﬁ-
cantly compared to those in control MEFs, although their levels were
similar in the total cell lysates (Fig. 4C). We also conﬁrmed that
enriching polyubiquitinated proteinswith TUBEs did not alter the ratios
of Ub conjugates between control andUbc−/−MEFs (Fig. 4C). Therefore,
the polyubiquitination and degradation of Nrf2 could be intrinsically in-
efﬁcient in Ubc−/−MEFs, presumably due to the reduced proteasomal
activity (see Fig. 2E) and to the reduced availability of Ub required for
these processes.
3.5. Increased basal levels of nuclear Nrf2 is responsible for high basal Nrf2
target gene expression in Ubc−/−MEFs
Intriguingly, the inefﬁcient or delayed onset of Nrf2 degradation also
affected the basal expression levels of the Nrf2 target genes Nqo1 and
Hmox1, which were signiﬁcantly higher in Ubc−/− MEFs than those
in control MEFs (Fig. 5A, NaAsO2 treatment for 0 h). The high basal
expression levels of Nrf2 target genes in Ubc−/−MEFs were not due to
Fig. 3. Increased Ub conjugate levels upon exposure to As(III). (A, B) Immunoblot detection of Ub conjugates (Ubn), free Ub (Ub1), and Nrf2 in control (Ubc+/−) and Ubc KOMEFs treated
with NaAsO2 or tBHQ for up to 10 h. Increased levels of Nrf2 target Hmox1 were detected in both groups with tBHQ treatment. α-Tubulin (α-Tub) was used as a loading control.
(C) Immunoblot detection of Ubn, Ub1, and Nrf2 in control (Nrf2+/−) and Nrf2 KO MEFs treated with NaAsO2 for up to 10 h. (D) Ubb and Ubc mRNA levels in control (Nrf2+/+ or
Nrf2+/−) and Nrf2 KO MEFs (n= 3 each) treated with 10 μM NaAsO2 for 5 h were determined by qRT-PCR. The mRNA levels are expressed as a fold increase relative to control MEFs
without NaAsO2 treatment. (E) Immunoblot detection of Ubn, Ub1, and Nrf2 in control (Ubb+/+) and Ubb KOMEFs treatedwith NaAsO2 for up to 10 h. Representative immunoblot results
from three differentMEFs per group are shown (A-C, E), and data are expressed as themeans±SEM from the indicated number of samples (D). ⁎P b 0.05 between two groups as indicated
by horizontal bars. NS, not signiﬁcant.
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Nqo1 and Hmox1 protein levels were also signiﬁcantly elevated in
Ubc−/−MEFs, even under normal conditions (Fig. 5B and see Fig. 3B).Fig. 4.Delayed onset of Nrf2 degradation in Ubc−/−MEFs. (A) Cycloheximide (CHX) chase of st
2 h to prevent degradation of Nrf2. Upon removal of MG-132, the accumulated Nrf2 in MEFs w
observed during chase. α-Tubulin (α-Tub) was used as a loading control. (B) Quantiﬁcation
chase using Image J software. Immunoblot signals of Nrf2 at a chase time 0 h were set to 100
8 h, and the polyubiquitinated proteins were subjected to pull down with Agarose-TUBEs. Inp
conjugates (Ubn) and Nrf2. α-Tub served as a control to show the TUBEs speciﬁcity. Quantiﬁ
Representative immunoblot results from three different MEFs per group are shown (A, C), an
⁎P b 0.05; ⁎⁎P b 0.01 vs. control MEFs at the chase time as indicated or between two groups asHowever, the increased basalmRNAandprotein levels of theNrf2 target
gene Nqo1 in Ubc−/− MEFs (see Fig. 5A-D) were less dramatic than
those in the livers from Rpt2 conditional knockout mice with defectiveabilized Nrf2. Control (Ubc+/−) and Ubc KOMEFs were pre-treated with 5 μMMG-132 for
as chased in media containing CHX for up to 2 h. No degradation of Keap1 or Nqo1 was
of Nrf2 levels in control (Ubc+/+ or Ubc+/−) and Ubc KO MEFs (n= 3 each) during CHX
% for each group. (C) Control (Ubc+/−) and Ubc KO MEFs were treated with MG-132 for
ut or eluted fractions from agarose resin were used for the immunoblot detection of Ub
cation of Ubn and Nrf2 levels in control and Ubc KO MEFs (n = 3 each) are also shown.
d data are expressed as the means ± SEM from the indicated number of samples (B, C).
indicated by horizontal bars.
Fig. 5.High basal expression of Nrf2 target genes due to increased basal levels of nuclear Nrf2. (A)Nrf2, Nqo1, and Hmox1mRNA levels in control (Ubc+/+) and Ubc KOMEFs (n=3 each)
treated with 10 μM NaAsO2 for up to 10 h were determined by qRT-PCR. The mRNA levels are expressed as a fold increase relative to control MEFs without NaAsO2 treatment.
(B) Immunoblot detection of Keap1, Nqo1, and Hmox1 in control (Ubc+/−) and Ubc KO MEFs treated with NaAsO2 for up to 10 h. α-Tubulin (α-Tub) was used as a loading control.
Band intensities of Nqo1 and Hmox1 in Ubc KOMEFs (Ubc−/−, n= 3) were expressed as a fold increase relative to those in control MEFs (Ubc+/+ or Ubc+/−, n= 3) under normal con-
ditions. (C) Nrf2, Nqo1, andHmox1mRNA levels in control (Ubc+/+) andUbc KOMEFs (n=3 each) infected with lentivirus harboring scrambled orNrf2 shRNAwere determined by qRT-
PCR. ThemRNA levels are expressed as a fold increase relative to controlMEFswith scrambled shRNA. (D) Immunoblot detection of Nrf2,Nqo1, andHmox1 in control (Ubc+/+) andUbcKO
MEFs infected with lentivirus harboring scrambled or Nrf2 shRNA. (E) Control (Ubc+/−) and Ubc KOMEFs were treated with NaAsO2 for up to 2 h. Nuclear or cytoplasmic fractions were
used for immunoblot analysis using anti-Nrf2 antibody. Lamin B and α-Tub were used as loading controls. Representative immunoblot results from three different MEFs per group are
shown (B,D, E), anddata are expressed as themeans±SEM from the indicatednumber of samples (A–C). ⁎P b 0.05; ⁎⁎P b 0.01, ⁎⁎⁎P b 0.001 between twogroups as indicated byhorizontal
bars. NS, not signiﬁcant.
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be more severe by the knockout of regulatory particle subunit gene
Rpt2 than by the knockout of polyubiquitin gene Ubc. In contrast, the
Keap1 protein levels were comparable between control and Ubc−/−
MEFs, regardless of stress conditions (Fig. 5B and see Fig. 4A).
To conﬁrm that the increased basal expression levels of Nrf2 targets
in Ubc−/− MEFs are indeed dependent on Nrf2, we employed a
lentivirus-mediated shRNA knockdown approach. As lentiviral infection
itself seemed to increase the basal expression levels of certain Nrf2 tar-
get genes,we comparedMEFs infectedwith shRNAagainstNrf2 to those
infected with scrambled shRNA (see Fig. 5D). The knockdown of Nrf2
decreased the Nrf2 target gene expression levels even in control MEFs,
reﬂecting the increased basal expression levels of Nrf2 target genes
upon viral infection (Fig. 5C). The knockdown of Nrf2 in Ubc−/−MEFs
decreased the basal expression levels of Nqo1 to those comparable tocontrol MEFs, while it decreased the basal expression levels of Hmox1
to those higher than the levels in control MEFs, probably because
Hmox1 expression is also regulated by the Nrf2-independent pathway
(Fig. 5C). Therefore, the increased basal expression levels of Nrf2 target
genes in Ubc−/−MEFs dependmostly on the increased levels of Nrf2 in-
side the nucleus. Immunoblot analysis revealed that the elevated basal
Nqo1 and Hmox1 protein levels in Ubc−/− MEFs were both reduced
by Nrf2 knockdown (Fig. 5D), which is consistent with the qRT-PCR
results.
Although it was hard to detect or compare the levels of Nrf2 in the
total cell lysates under normal conditions between control and Ubc−/−
MEFs, the basal levels of nuclear Nrf2 were higher in Ubc−/− MEFs
than in control MEFs (Fig. 5E, left). In addition, within 2 h of NaAsO2
treatment, the levels of nuclear Nrf2 became comparable. In contrast
to nuclear Nrf2, no signiﬁcant changes in the levels of cytoplasmic
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right). These data support our observation that the basal expression
levels of Nrf2 targets increased in Ubc−/−MEFs.
3.6. Altered response of Nrf2 target gene expression in Ubc−/−MEFs upon
exposure to As(III)
Upon exposure to As(III), the expression levels of the Nrf2 target
genes Nqo1 and Hmox1 dramatically increased in both control and
Ubc−/−MEFs (Fig. 5A), but the fold increases in Ubc−/−MEFswere con-
siderably less than those in control MEFs (see Supplementary Fig. S2).
This was mostly attributed to the high basal expression levels of the
Nrf2 target genes (Fig. 5A). Despite the decreased fold induction of theFig. 6.Decreased polyubiquitination of misfolded proteins in Ubc−/−MEFs generated under oxi
(Ubc+/−) and Ubc KOMEFs treated with NaAsO2 or tBHQ for up to 10 h. α-Tubulin (α-Tub) w
10 μM NaAsO2 for 10 h to induce protein misfolding and polyubiquitination. After washing ou
analysis for up to 48 h. NaAsO2 washout also caused rapid degradation of Nrf2 and a gradual
and LC3B in control (Ubc+/−), Ubc KO, and Nrf2 KO MEFs treated with NaAsO2 for up to 10
(E) Immunoblot detection of Ubn, Nrf2, p62, and LC3B in control (Ubc+/−) and Ubc KOMEFs p
or autophagy during washout, 0.1% DMSO (DM, as a vehicle), 0.5 μMMG-132 (MG), or 0.1 μM
MEFs per group are shown.Nrf2 target genes Nqo1 and Hmox1 in Ubc−/− MEFs, their mRNA and
protein levels reached those of control MEFs following exposure
to As(III) (Fig. 5A and B). Therefore, the activation of the Nrf2–Keap1
pathway may not be dependent on the cellular Ub levels. In addition,
the suppression of theNrf2–Keap1 pathway via Nrf2 knockdown further
reduced the viability of both control and Ubc−/−MEFs (see Supplemen-
tary Fig. S3), which also demonstrates that Nrf2 plays a protective role
regardless of the cellular Ub levels. However, the decreased fold
induction of the Nrf2 target genes in Ubc−/− MEFs could be due to
cellular desensitization against oxidative stress or to a limited availabil-
ity of relevant factors required for the cytoprotective response.
Therefore, cellular detoxiﬁcation via the Nrf2–Keap1 pathway may not
be sufﬁcient to overcome the cytotoxicity in Ubc−/−MEFs.dative stress induced by As(III). (A, B) Immunoblot detection of Hsp70 and Hsf1 in control
as used as a loading control. (C) Control (Ubc+/−) and Ubc KOMEFs were pretreated with
t NaAsO2, Ub conjugates (Ubn), free Ub (Ub1), and Hsp70 were detected by immunoblot
decline of the Nrf2 target proteins Nqo1 and Hmox1. (D) Immunoblot detection of p62
h. Autophagosome formation was estimated from the conversion of LC3B-I to LC3B-II.
retreated with NaAsO2, as in (C), and washed out for 24 h. To inhibit proteasomal activity
Baﬁlomycin A1 (BA) was added. Representative immunoblot results from three different
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by As(III) are not properly polyubiquitinated in Ubc−/−MEFs
Under oxidative stress conditions, proteins are prone to be
misfolded, and these misfolded proteins are polyubiquitinated to be
targeted to and degraded by the proteasome [44,45]. In particular,
As(III) induces protein misfolding by interfering with the activity of
chaperones and triggers protein aggregation in yeast [46]. In fact, expo-
sure of MEFs to As(III), but not to tBHQ, induced similar levels of heat-
shock protein 70 (Hsp70) in control, Ubc−/−, and Nrf2−/− MEFs
(Fig. 6A and B, top panels, and data not shown), suggesting that Ubc or
Nrf2 disruption does not affect the induction of Hsp70. Upon exposure
to As(III), the heat-shock transcription factor Hsf1 was also activated,
as judged by its hyperphosphorylation (as indicated by asterisks in
Fig. 6A, bottom panel). The activation of Hsf1 seemed to upregulate
the Hsp70 levels, as hyperphosphorylation of Hsf1 was most evident
at 5 h after As(III) exposure, but Hsp70 induction reached its maximum
levels at a later time. The activation of Hsf1 or induction of Hsp70 was
not observed with tBHQ treatment (Fig. 6B). Our data are consistent
with the previous report [58], which demonstrated that Hsf1, but not
Nrf2, was responsible for the upregulation of Hsp70. Therefore, the in-
duction of Hsp70 clearly indicates that misfolded proteins were gener-
ated, which was independent of the activation of the Nrf2–Keap1
pathway.
Upon exposure to As(III), the increased levels of Ub conjugates may
represent polyubiquitinated misfolded proteins to be degraded by the
proteasome (Fig. 6C). Upon removal of NaAsO2, these misfolded pro-
teins were either refolded by Hsp70 or degraded by the proteasome,
thereby decreasing the levels of Ub conjugates, more prominently in
control MEFs (Fig. 6C). The levels of Ub conjugates did not decrease
when proteasomal activity was inhibited after removal of NaAsO2,
but decreased when autophagy was inhibited, conﬁrming that the pro-
teasome is responsible for the degradation of polyubiquitinated
misfolded proteins (Fig. 6E). Due to the reduced availability of cellular
Ub in Ubc−/− MEFs, misfolded proteins could not be adequately
polyubiquitinated; therefore, it is possible that misfolded proteins
could accumulate inside the cells, forming insoluble protein aggregates
instead of being targeted to the proteasome. However, upon removal of
NaAsO2, the levels of Hsp70 declined gradually in both control and
Ubc−/−MEFs, suggesting that refolding by Hsp70 was not inﬂuenced
by cellular Ub levels. The gradual decline in the Nrf2 target proteins
Nqo1 and Hmox1 was delayed in Ubc−/− MEFs, indicating the
decreased proteasomal activity or prolonged activation of the Nrf2–
Keap1 pathway, probably because the cells could not fully recover
from the stress conditions (Fig. 6C).
Although it was expected that accumulated misfolded protein
aggregates would be removed by autophagy, autophagic ﬂux could
be impaired under As(III) exposure by inhibiting the clearance of
autophagosomes, resulting in the accumulation of autophagosomes
and p62 [29–31]. In fact, upon exposure to As(III), Nrf2-independent ac-
cumulation of p62 and increased levels of LC3B-IIwere observed in both
control andUbc−/−MEFs (Fig. 6D and E). Therefore, induction of the au-
tophagic pathway per semay not be affected by the levels of cellular Ub.
Rather, recognition of the accumulated misfolded proteins by p62,
which serves as a polyubiquitin chain bindingprotein, could be compro-
mised when cellular Ub levels are reduced, probably because of the
short chain length of Ub. Taken together, the removal of accumulated
misfolded protein aggregates by autophagy in Ubc−/−MEFs is hardlyFig. 7. Increased formation of large-sizedUb-positive puncta inUbc−/−MEFsupon exposure to A
subjected to immunoﬂuorescence analysis using anti-Ub (FK2) and anti-Nrf2 antibodies, and D
NaAsO2 treatment, NaAsO2 was washed out, and theMEFs were incubated for another 24 h. Re
total number of Ub-positive puncta in a given cell, the total number of Ub-positive puncta with
puncta in control (Ubc+/+) andUbcKOMEFs (n=3each)was carried out in 30 randomly select
divided into four groups based on their particle areas. Extra small puncta were assigned to grou
large puncta were assigned to group 3. All data are expressed as the means ± SEM from the
indicated by horizontal bars. NS, not signiﬁcant. Scale bar, 50 μm.likely to occur under As(III) exposure due to the impaired autophagic
ﬂux. Furthermore, although the increased activity of the autophagic
pathway was expected when proteasomal activity was impaired [57],
there is no evidence so far that the activity of the autophagic pathway
is increased in Ubc−/−MEFs, even after removal of NaAsO2.
3.8. Formation of large-sized Ub-positive puncta increases upon exposure to
As(III) and their clearance is delayed in Ubc−/−MEFs
The accumulation of misfolded protein aggregates could be toxic to
cells. The proteasome is responsible for the clearance of misfolded pro-
teins before they accumulate as insoluble protein aggregates; therefore,
we hypothesized that adequate polyubiquitination and degradation of
misfolded proteins are essential to confer resistance against cytotoxicity
induced by As(III). In fact, when control and Ubc−/−MEFs were treated
with NaAsO2 for 10 h, the number of Ub-positive puncta, which may
represent both misfolded proteins and insoluble protein aggregates, in-
creased signiﬁcantly, and Nrf2 translocated into the nucleus in both ge-
notypes of cells (Fig. 7A and B). The total number of Ub-positive puncta
in a given cell was not signiﬁcantly different in control andUbc−/−MEFs
(Fig. 7B), although the levels of Ub conjugates were much lower in
Ubc−/−MEFs exposed to As(III) (see Figs. 3A and 6C). The Ub-positive
puncta in a given cell were divided into four groups based on their
size. Only the number of large-sized Ub-positive puncta in a given cell
was signiﬁcantly higher in Ubc−/− MEFs than that in control MEFs
(Fig. 7C,middle). Furthermore, althoughUb-positive punctaweremost-
ly cleared within ~24 h in control MEFs after removal of NaAsO2, the
clearance of large-sized Ub-positive puncta was signiﬁcantly delayed
inUbc−/−MEFs (Fig. 7C, right and see Supplementary Fig. S4). These re-
sults suggest that inadequately polyubiquitinated misfolded proteins in
Ubc−/−MEFs under oxidative stress conditions may not be good sub-
strates for the proteasome; therefore, these proteins tend to accumulate
inside the cells as large protein aggregates. Under this circumstance, the
availability of Ub could be further reduced in Ubc−/−MEFs, as Ubs were
sequestered with insoluble protein aggregates, which should normally
be recycled after the proteasomal degradation of polyubiquitinated pro-
teins [39]. Therefore, the increased formation and/or delayed clearance
of polyubiquitinated large protein aggregates in Ubc−/−MEFs can cause
cytotoxicity.
We then investigated how Ub-positive puncta are cleared upon re-
moval of As(III). As misfolded proteins are usually degraded by the
proteasome while insoluble protein aggregates are removed by the au-
tophagic pathway [59], we investigated the clearance of Ub-positive
puncta generated upon NaAsO2 treatment in the presence of a protea-
some or an autophagy inhibitor. Intriguingly, the Ub-positive puncta
were cleared by both the proteasome and the autophagic pathway
(see Supplementary Fig. S4), in contrast to Ub conjugates, which were
cleared by the proteasome only (see Fig. 6E). Based on these data, Ub
conjugates generated with NaAsO2 treatment represent misfolded pro-
teins that can be degraded by the proteasome; and Ub-positive puncta
generated with NaAsO2 treatment represent both misfolded proteins
and insoluble protein aggregates. In Ubc−/−MEFs, due to the reduced
function of the proteasome (see Fig. 2E), it is highly likely that more
misfolded protein aggregates accumulate inside the cells, forming
large protein aggregates. Furthermore, no obvious activation of the au-
tophagic pathway or potential impairment of an autophagy adaptor
protein p62 in recognizing large protein aggregates may delay their
clearance. Therefore, the residual protein aggregates that were nots(III).(A) Control (Ubc+/+) andUbcKOMEFswere treatedwith 10 μMNaAsO2 for 10 h and
NAwas visualized with DAPI. To determine the clearance of Ub-positive puncta formed by
presentative images from three different MEFs per group are shown. (B) To determine the
pixel intensity above the threshold levels was counted on a per cell basis. Quantiﬁcation of
ed cells per sample (90 cells per group). (C) Ub-positive puncta, as determined in (B),were
p 0, small puncta were assigned to group 1, medium puncta were assigned to group 2, and
indicated number of samples. ⁎P b 0.05; ⁎⁎P b 0.01, ⁎⁎⁎P b 0.001 between two groups as
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cells and are eventually responsible for cell death.
4. Discussion
The polyubiquitin gene Ubc is upregulated upon exposure to As(III)
[38]. However, it remains unknown why Ubc is upregulated under
As(III) exposure and the role of Ub to confer resistance against the cyto-
toxicity induced by As(III) has not been identiﬁed. Due to the increased
demand for Ub under various stress conditions, and also to the high con-
tribution of Ubc toward total Ub levels in MEFs, Ubc−/−MEFs can serve
as a good model for Ub-deﬁciency, particularly under oxidative stress
conditions. Therefore, investigating how the antioxidant response
system is regulated in Ubc−/− MEFs could provide valuable insight
into the molecular mechanism for the role of Ub in cellular defense
pathways.
As(III) is an environmental contaminant, found particularly in drink-
ing water, and causes cellular toxicity by increasing ROS production
[60]. Cells respond to oxidative stress induced by As(III) by activating
the Nrf2–Keap1 pathway in a p62-dependent manner, which is a non-
canonical mechanism of Nrf2 activation [29–31]. As(III) causes protein
misfolding and triggers the formation of protein aggregates in yeast
[46]. However, it is unknown whether or not the antioxidant response
pathway is dependent on cellular Ub levels and what the role of Ub is
in protecting cells against cytotoxicity caused by As(III).
The enhanced sensitivity of Ubc−/−MEFs against oxidative stress in-
duced by As(III) prompted us to hypothesize that the maintenance of
cellular Ub levels is important for antioxidant response (see Fig. 1A).
To test our hypothesis, we investigated whether activation of the
Nrf2–Keap1 pathway upon exposure to As(III) depends on cellular Ub
levels (see Fig. 3A and E). We found that the upregulation of Ubc upon
exposure to As(III) occurred through two distinct and non-redundant
pathways; one was Nrf2 dependent and the other was Nrf2 indepen-
dent (Fig. 8 and see Fig. 3D). The exactmechanism of howpolyubiquitin
genes sense oxidative stress conditions and increase their expression in
an Nrf2-independent manner remains unknown. Nevertheless, the
upregulation of Ubc is part of the cytoprotective response that not
only increases levels of antioxidants and detoxifying enzymes to confer
resistance against oxidative stress, but also increases the Ub levels and
activities of the chaperones and the proteasome (Fig. 8). Ub plays an
essential role in polyubiquitinating misfolded proteins and targeting
them to the proteasome for degradation; otherwise, these misfoldedFig. 8. Schematic representation. Upregulation of polyubiquitin genes viaNrf2-dependent and i
mation under oxidative stress induced by As(III).proteins tend to aggregate, and thus cannot be easily removed by the
proteasome. It is highly likely that accumulations of these Ub-positive
protein aggregates cause cytotoxicity and eventually trigger apoptosis
(Fig. 8).
As previously reported [21–24], we determined that Nrf2 is an ex-
tremely good substrate for the proteasome, as it is rapidly degraded
under normal conditions. However, due to inefﬁcient polyubiquitination
of Nrf2 and/or inefﬁcient targeting to the proteasome, the onset of Nrf2
degradation was signiﬁcantly delayed when cellular Ub levels were re-
duced (see Fig. 4A and B), resulting in the increased basal levels of nucle-
ar Nrf2 and high basal mRNA and protein levels of the Nrf2 target genes
inUbc−/−MEFs (see Fig. 5A, B, and E). Based on a recentmodel of the in-
teraction between Nrf2 and Keap1 [61], inefﬁcient polyubiquitination of
Nrf2 under normal conditions could hamper the release of Nrf2 from
Keap1, thereby reducing the number of available free Keap1 dimers
that can interactwith newly synthesized Nrf2, and these Nrf2 can poten-
tially translocate into the nucleus. Therefore, the delayed onset of Nrf2
degradation in Ubc−/−MEFs could, at least in part, explain the increased
basal levels of nuclear Nrf2 and high basal levels of Nrf2 targets under
normal conditions. Although we expected that high basal levels of Nrf2
targets in Ubc−/− MEFs could desensitize the antioxidant response
against oxidative stress, their levels also increased and reached those of
control MEFs under oxidative stress induced by As(III). This could be
because the levels of Nrf2 under Ub deﬁciency were lower than those
under oxidative stress conditions, therefore further activation of Nrf2
was possible upon exposure to As(III). Because polyubiquitination does
not occur in Nrf2 bound to Keap1 under stress conditions, and newly
synthesized Nrf2 is translocated into the nucleus [61], it is quite reason-
able to speculate that Nrf2 levels in the nucleus may not be affected by
cellular Ub levels under oxidative stress conditions. Based on these ob-
servations, we conclude that activation of the Nrf2–Keap1 pathway
may not critically depend on cellular Ub levels.
Under oxidative stress conditions or upon exposure to As(III), it has
been well known that misfolded proteins are generated, and are
polyubiquitinated and targeted to the proteasome for degradation. If
the rate of formation of misfolded proteins exceeds the degradation ca-
pacity of the proteasome, polyubiquitinated misfolded proteins start to
accumulate. At an early stage, polyubiquitinated misfolded protein
monomers or oligomers can be detected as Ub conjugates, but at a
later stage, they form polyubiquitinated misfolded protein aggregates
thatmay be insoluble [59]. TheUb-positive punctamost likely represent
both populations; therefore, their levels may not correlate with those ofndependent pathways confers a cytoprotective response to alleviate protein aggregate for-
1008 M.-N. Kim et al. / Biochimica et Biophysica Acta 1853 (2015) 996–1009the Ub conjugates observed in immunoblot analysis (see Figs. 6C and
7B). In fact,when using the same anti-Ub antibody (FK2), the total num-
ber of Ub-positive puncta did not signiﬁcantly differ between control
and Ubc−/−MEFs upon exposure to As(III) (see Fig. 7B), although levels
of Ub conjugates dramatically increased in control MEFs, but not in
Ubc−/−MEFs (Kim et al., unpublished data), These observations clearly
indicate that there are more misfolded protein aggregates in Ubc−/−
MEFs than in control MEFs upon exposure to As(III), which was also
demonstrated by the increased number of large-sized Ub-positive
puncta in Ubc−/−MEFs (see Fig. 7C). In addition, the disappearance of
Ub conjugates and Ub-positive puncta upon removal of As(III) corre-
lates well with the reduction of Hsp70 levels, which clearly indicates
that Ub conjugates and Ub-positive puncta comprise polyubiquitinated
misfolded proteins.
Proteins tend to misfold under oxidative stress conditions, and can
be refolded by chaperones such as Hsp70 or removed by the protea-
some if refolding is not possible [44,45,62,63]. Failure to remove these
misfolded proteins can result in the accumulation of protein aggregates,
which are potentially toxic to cells [64,65]. Therefore, it is reasonable
to speculate that the increased cellular demand for Ub under oxidative
stress is to polyubiquitinate and degrade misfolded proteins or
protein aggregates in order to alleviate cytotoxicity. However, when cel-
lular Ub levels are low, misfolded proteins cannot be efﬁciently
polyubiquitinated, resulting in the accumulation of protein aggregates.
In this study, we found that the number of large-sized Ub-positive
protein aggregates was higher in Ubc−/−MEFs under oxidative stress
induced by As(III) (see Fig. 7C). Furthermore, clearance of these large-
sized aggregates was delayed in Ubc−/− MEFs. Therefore, enhanced
sensitivity against oxidative stress induced by As(III) in Ubc−/−MEFs
could be primarily due to the cytotoxicity caused by the accumulation
of protein aggregates. As the accumulation of polyubiquitinated protein
aggregates will eventually result in insoluble protein deposits, cellular
Ub is sequestered into these insoluble components; therefore, the avail-
ability of Ub becomes further limited,which aggravates the likelihood of
cellular survival.
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